Browsing Tag
Medicines and Healthcare products Regulatory Agency
6 posts
Can weight loss drugs cause fatal pancreas illness? UK raises red flag on GLP-1 therapies
UK strengthens pancreatitis risk warning for GLP-1 weight loss and diabetes drugs like Wegovy and Mounjaro. Find out what it means for health systems and pharma.
UK fast-tracks clinical trials with 14-day reviews and AI simulation support to regain R&D edge
Find out how MHRA’s 2026 trial reforms—fast-track routes, AI models, and 14-day reviews—aim to make the UK a global leader in clinical research again.
UK approves first-ever immunotherapy for type 1 diabetes — can teplizumab really delay onset by three years?
MHRA approves teplizumab, the UK’s first immunotherapy for type 1 diabetes, delaying onset by three years. See how it could reshape care pathways.
Can faster CAR-T turnaround save more lives under the UK’s new point-of-care manufacturing rules?
The UK’s new point-of-care rules promise faster CAR-T therapy turnaround—find out how this could improve cancer survival rates and expand NHS access.
How UK’s new point-of-care drug manufacturing rules will transform cancer and gene therapies
The UK’s world-first point-of-care manufacturing law transforms advanced therapy delivery—discover how it changes cancer and gene therapy access.
UK approves Lilly’s Alzheimer’s drug but labels it ‘too expensive’ for NHS use
The UK has approved Eli Lilly’s new Alzheimer’s treatment, donanemab, which has shown promise in slowing cognitive decline.…